Ascendia - Making the Impossible Possible for Over a Decade

Identifying the Right CDMO to Support Biopharma Manufacturing

Published on: 

Sponsored Video

New Opportunities via Novel Formulation Technologies
Now Viewing
Identifying the Right CDMO to Support Biopharma Manufacturing
Optimizing Drug Delivery Methods With Nanotechnologies

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:

  • What to look for when identifying a CDMO for a drug development project
  • Ascendia Pharmaceuticals and its expansion of manufacturing services
  • Ascendia Pharmaceuticals as a "Partner of Choice"